Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan.

Chiu, H-Y; Hsueh, P-R; Tsai, T-F

Chiu, H-Y; Hsueh, P-R; Tsai, T-F.

Affiliation

Chiu HY; Department of Dermatology National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.

Br J Dermatol ; 164(3): 553-9, 2011 Mar.

Article in En | MEDLINE | ID: mdl-21083541

Subject(s)

Anti-Inflammatory Agents/therapeutic use; Immunoglobulin G/therapeutic use; Latent Tuberculosis/diagnosis; Psoriasis/drug therapy; Receptors, Tumor Necrosis Factor/therapeutic use; Tuberculin Test/methods; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Adalimumab; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Child; Etanercept; Female; Humans; Male; Mass Screening/methods; Middle Aged; Psoriasis/complications; Retrospective Studies; Taiwan; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Immunoglobulin G / Tuberculin Test / Tumor Necrosis Factor-alpha / Receptors, Tumor Necrosis Factor / Latent Tuberculosis / Anti-Inflammatory Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Br J Dermatol Year: 2011 Type: Article Affiliation country: Taiwan

Fulltext

XML

PubMed Links

Search on Google